Shock wave therapy for erectile dysfunction after prostate surgery
Treatments studied
Part of Kidney & urinary, Mental health clinical trials.
This study tests whether low-intensity shock wave therapy can help improve erectile function after robotic prostatectomy for low-risk prostate cancer. It is for men who already had fairly good erections before surgery and want to see if this non-invasive treatment can help their recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years old or younger.
- You had low-risk prostate cancer (PSA less than 10, Gleason score less than 7) and a nerve-sparing robotic prostatectomy.
- Your erectile function before surgery was already fairly good (score of 17 or higher on a standard questionnaire).
- Your first PSA test after surgery (about 45 days later) was less than 0.2.
- You are willing to follow the study plan and fill out questionnaires about your erectile function and quality of life.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether shockwave therapy—a non-invasive treatment that uses sound waves—can help improve erectile dysfunction. If you qualify, you'll receive shockwave treatments and answer questions about your sexual function over time.
This trial compares two types of low-intensity wave therapy to see which works better for erectile dysfunction and/or chronic pelvic pain. Participants may benefit if these therapies improve erection quality and reduce pelvic pain.
This trial compares two treatments for erectile dysfunction (ED): platelet-rich plasma (PRP, made from your own blood) alone, or PRP combined with low-intensity shock wave therapy (sound waves applied to the penis). PRP is thought to help repair tissue, and shock waves may improve blood flow. The goal is to see if adding shock waves works better than PRP alone.
This Phase 2 study tests how safe and effective a topical medicine (BZ371A) is for men after prostate surgery, with the goal of improving sexual recovery and monitoring side effects. You may be able to join if you meet specific timing, health, and medication criteria after radical prostatectomy.
This trial studies whether daily tadalafil (5 mg) can improve early urinary trouble and erection function after endoscopic prostate tissue removal. It may help men whose urinary symptoms continued even after prior medicine.
This trial combines a low-intensity shockwave treatment with a commonly used injectable medication (collagenase) to see if the combination works better for men with Peyronie's disease who have a noticeable curve and a non-calcified plaque.
Hear when a new Erectile Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.